In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Marta Carretero-Ledesma *Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0002-6400-0830 Carlos Saúco-Carballo *Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0002-4428-3917 Ana Velázquez EscuderoClinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.
Inmaculada López-HernándezClinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0002-0204-1303 Inés Portillo-CalderónClinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0003-1692-9538 Lorena López-CereroClinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0001-8950-4384 José Manuel Rodríguez-MartínezInstitute of Biomedicine of Seville IBIS, Virgen Macarena University Hospital/CSIC/University of Seville, Seville, Spain.ORCID 0000-0002-2228-2294 Jesús Rodríguez BañoClinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0001-6732-9001 Álvaro Pascual *Clinical Unit of Infectious Diseases and Microbiology, Virgen Macarena University Hospital, Seville, Spain.ORCID 0000-0002-8672-5891 Fernando Docobo-Pérez *Institute of Biomedicine of Seville IBIS, Virgen Macarena University Hospital/CSIC/University of Seville, Seville, Spain.ORCID 0000-0003-4038-6764 Funding
CIBER-INFEC 3227/3739Instituto de Salud Carlos III FI23/00026Instituto de Salud Carlos III JR24/00048Instituto de Salud Carlos III PI22/00914
6 · The paper itselfAbstract
Routine susceptibility testing often misses resistance in
Indexed as
Anti-Bacterial Agentsbeta-LactamasesCefepimeEscherichia coliPenicillanic AcidCephalosporinsDisk Diffusion Antimicrobial TestsHumansMicrobial Sensitivity TestsPiperacillinPiperacillin, Tazobactam Drug CombinationThird Generation CephalosporinsAnti-Bacterial Agentsbeta-LactamasesCefepimeCephalosporinsPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationThird Generation Cephalosporinsantimicrobial susceptibility testingblaOXA-1broth microdilutiondisk diffusionEscherichia coliMicroScan
Identifiers
PMID42363836
PMCPMC13436281
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390